Evidence map›Paper›PMID 42080550›Full record

Observational studyAntimicrobial agents and chemotherapy2026

Empirical glycopeptide exposure and acute kidney injury during cloxacillin therapy in

Miguel Ángel Verdejo, Daniela Malano-Barletta, Cristina Pitart, Marta Hernández-Meneses, Guillermo Cuervo, Marta Bodro, Carolina García-Vidal, Néstor Lopez, Sabina Herrera, Ana Del Río and 5 more

Abstract readObservational Study
In one paragraph

Observational study in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Miguel Ángel VerdejoInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0000-0001-7870-0515
Daniela Malano-BarlettaInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Cristina PitartFaculty of Medicine, University of Barcelona, Barcelona, Spain.
Marta Hernández-MenesesInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Guillermo CuervoInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Marta BodroInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0000-0002-0520-8279
Carolina García-VidalInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0000-0002-8915-0683
Néstor LopezInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Sabina HerreraInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ana Del RíoInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Mateu EspasaFaculty of Medicine, University of Barcelona, Barcelona, Spain.
Climent CasalsFaculty of Medicine, University of Barcelona, Barcelona, Spain.
Josep MensaInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Laura MorataInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.
Alex SorianoInfectious Diseases Department, Hospital Clínic Barcelona, Barcelona, Spain.

Funding

Instituto de Salud Carlos III JR23/00025
6 · The paper itself

Abstract

We aimed to identify risk factors for the development of acute kidney injury (AKI) during treatment of

Indexed as

Acute Kidney InjuryAnti-Bacterial AgentsBacteremiaCloxacillinGlycopeptidesStaphylococcal InfectionsStaphylococcus aureusAgedAged, 80 and overCefazolinFemaleFirst Generation CephalosporinsHumansMaleMiddle AgedProspective StudiesAnti-Bacterial AgentsCefazolinCloxacillinFirst Generation CephalosporinsGlycopeptidesacute kidney injurycefazolincloxacillinglycopeptidesnephrotoxicityStaphylococcus aureus bacteremia

Identifiers

PMID42080550
PMCPMC13231869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.